News & Articles

The introduction of a digital alert system to monitor patients with sepsis has led to a reduction in deaths and hospital stays

International panel of pathologists drive progressive agenda on the role of pathology in transforming cancer diagnostics and improving patient care

Proximity will facilitate local and international sponsor access to Kayentis’ eCOA services for mid- to later-stage clinical trials

Developing accident tolerant fuels to make nuclear fission safer in the event of accident scenarios

The partnership will offer unique patient-derived 3D cell culture services to drug development researchers

Rapid 3D imaging and in-depth structural analysis opens up quality monitoring and spermatozoa selection for artificial insemination in humans and animals

SciLifeLab and UCL team use in situ sequencing to produce first spatial map of closely related brain tissue cells

2020 show set for November 4 & 5 with 84% of stand space already rebooked by returning exhibitors following this year’s success

Instrument is designed to reduce the number of parts requiring disinfection after use

Adakveo targets key molecule for the prevention of sickle cell pathology

New artifical intelligence algorithm could be the future of drug delivery

Accurate and detailed protein interactions analysis under near-native conditions with an easy-to-use system

LG Chem selects second and third drug targets following rapid progress in first program

Sartorius Intellicyt addresses challenges such as high cost and purification difficulties and presents possible solutions

Cross-industry collaboration will accelerate digital solutions and support R&D innovation by customers

Newly discovered antibodies promise significant improvement over current therapies

Thermo Fisher Scientific Orbitrap GC-MS technology to be integrated into Breath Biopsy to support identification of novel biomarkers for early disease detection

Hitachi and the Centre Leon Berard Cancer Center to launch research into diagnosis and treatment

Envigo enters CRISPR gene-edited research model field with the addition of Horizon’s business